-- NuCell Regenerative Health, an alternative pain treatment practice based in Narberth, Pennsylvania, announces an update in their treatment offerings for effective chronic pain relief. As an early adopter of the FDA cleared Neurostimulation treatment, NuCell offers treatment state-wide from Erie/Pittsburgh to Greater Philadelphia, and will pre-qualify patients for full insurance coverage prior to treatment. Non-narcotic and non-invasive, this temporary treatment device produces months of chronic pain relief and is supported by Medicare approved protocols (CMS).
More information can be accessed at: https://www.nucellregen.com/pain-management#neurostimulation
The latest announcement is in line with NuCell’s vision of providing services that are covered by insurance and are highly effective, non-invasive solutions to treat chronic pain including: neuropathy, fibromyalgia, arthritis, joint pain, migraine, sciatica, vascular insufficiency, cervical, thoracic and lumbar back pain, craniofacial pain including TMJ, shingles.
And can aid in the treatment of:
Craving Reduction for weight-loss, addiction, muscle spasms, anxiety, depression and insomnia
Clinical trials show that neurostimulator devices are highly effective for reducing pain. If other treatments haven’t worked, neurostimulation might be your next best option. FDA cleared device with FDA and CMS approved protocols.
Clinical trials show that neurostimulator devices are highly effective for reducing pain. If other treatments haven’t worked, neurostimulation might be your next best option. FDA cleared class 2 medical device with FDA and CMS approved protocols.
In addition to Medicare, treatment with this specific device is also covered by most major health insurance plans in Pennsylvania and the tri-state area. The device is fitted behind the patient’s ear and linked to four electrodes that are attached to nerves in the ear, administering a continuous pulse of low-level electrical current. After 10-12 days, 7 out of 10 patients report significant round-the-clock pain relief for 3-6 months.
Continuous studies suggest that the Neurostimulator can also be effective for more complex medical ailments such as Parkinson’s disease, Depression and Epilepsy. Therefore, in addition to targeting chronic pain, the Neurostimulator can act as a good pre-cursor or trial for clients wishing to seek a more permanent solution. Effective protocols are offered specifically to alleviate the side effects of drug detoxification during opioid withdrawal. The device sends continuous electrical pulses through nerves providing relief from the common withdrawal symptoms including stomach cramps, muscle aches, muscle spasms, pounding heart, nausea, vomiting, diarrhea, agitation, depression and insomnia, along with drug cravings.
Studies have shown that neurostimulation impacts on the release of neurotransmitters. By changing the concentration of neurotransmitters in specific brain regions, neuromodulation may modify the intrinsic properties of neuron membrane thus altering the response to synaptic events.
A free 30-minute tele-consultation with a member of the medical team can be booked via NuCell’s website. Interested parties can arrange an appointment by accessing:
Interested parties can find out more information by accessing: https://www.nucellregen.com/pain-management#neurostimulation
Release ID: 89016954